TENORETIC 50 pharmaceutical API fine chemical suppliers

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
J&H Chemical Co.,ltd	⤷ Get Started Free	JH461903	⤷ Get Started Free
RR Scientific	⤷ Get Started Free	R373601	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 18, 2025

Introduction

TENORETIC 50, a widely prescribed antihypertensive agent, combines atenolol and chlorthalidone to manage blood pressure effectively. As a combination therapy, its active pharmaceutical ingredients (APIs)—atenolol and chlorthalidone—are sourced from diverse manufacturing hubs globally. Robust sourcing strategies are critical for ensuring quality, supply chain consistency, and regulatory compliance. This analysis offers a comprehensive overview of potential bulk API sources for TENORETIC 50, focusing on strategic procurement considerations and supplier landscape.

Understanding the APIs in TENORETIC 50

Atenolol, a beta-1 adrenergic receptor blocker, reduces cardiac output, while Chlorthalidone, a thiazide-like diuretic, lowers blood volume by promoting sodium and water excretion. Both APIs require high purity and stringent quality control due to their therapeutic applications.

Global API Manufacturing Landscape

The API manufacturing industry has experienced significant globalization, with key producers spanning the United States, Europe, India, China, and other emerging markets. Manufacturing quality, regulatory compliance, and cost-effectiveness drive supplier selection.

1. Major API Producers for Atenolol

India
- Sun Pharmaceutical Industries Ltd.: Notable for global API supply with WHO-GMP compliance.
- Lupin Limited: Recognized for high-quality APIs; registered in major markets.
- Aurobindo Pharma: Extensive production facilities with strict quality assurance.
China
- HuaTec Corporation: Growing presence in beta-blocker API synthesis.
- Shanghai Pharmaceutical subsidiaries: Some manufacturing of atenolol APIs.
Europe and North America
- Less dominant for atenolol production, primarily relying on India and China for bulk supplies.

2. Major API Producers for Chlorthalidone

India
- Etheon Healthcare: Known for producing high-grade diuretics.
- Doctor Reddy's Laboratories: Offers chlorthalidone API compliant with international standards.
China
- Several manufacturers provide chlorthalidone APIs, emphasizing cost and compliance.
Europe/North America
- Production is mostly captive or via negotiated supply chains due to stringent regulatory standards.

Key Criteria in API Sourcing

Regulatory compliance: WHO-GMP, US FDA, EMA approvals.
Quality assurance: Consistent potency, low impurities, and stability.
Supply reliability: Capacity to meet demand fluctuations.
Cost-effectiveness: Competitive pricing without compromising quality.
Certifications and audits: Good manufacturing practice audits, environmental compliance.

Strategic API Sourcing Approaches

Single-source vs. Multiple-supplier strategy: Balances risk mitigation with cost management.
Vertical integration: Some manufacturers produce both APIs and finished forms, reducing supply chain complexity.
Contract manufacturing organizations (CMOs): Outsourcing API production to specialized facilities ensures quality and capacity.

Emerging Trends and Considerations

Regulatory harmonization influences sourcing choices, favoring API suppliers with recognized certifications.
Quality by Design (QbD) approach is increasingly adopted by API manufacturers, aligning with global regulatory expectations.
Supply chain resilience emphasizes diversified sourcing, especially crucial amid geopolitical tensions and pandemic disruptions.
Environmental sustainability in API manufacturing is gaining prominence, influencing supplier selection.

Case Study: API Sourcing for Generic TENORETIC 50

A typical procurement framework involves:

Confirming suppliers with WHO-GMP or equivalent certifications.
Conducting supplier audits, including quality systems, manufacturing processes, and environmental compliance.
Securing Certificates of Analysis (CoA), Stability Data, and batch documentation.
Establishing long-term agreements with multiple suppliers for both atenolol and chlorthalidone, ensuring backup options.

Regulatory and Quality Trends in API Supply

Regulatory authorities emphasize API quality, as deviations impact product safety and efficacy. Recent initiatives, such as the US DSCSA and EU FMD, reinforce traceability and authenticity, demanding transparent supply chains for APIs.

Manufacturers must maintain comprehensive documentation, validation protocols, and perform regular audits of API suppliers to ensure continued compliance.

Conclusion

The sourcing landscape for the APIs in TENORETIC 50 is complex yet strategic. Leading API suppliers from India and China dominate, with established quality standards and cost advantages. European and North American sources remain viable for specialized or high-regulatory-standard supply chains. A diversified supplier base, coupled with stringent qualification, helps mitigate risks and ensures consistent drug supply.

Key Takeaways

Global diversification in API sourcing enhances supply chain resilience.
Stringent quality standards and regulatory compliance are paramount when selecting API suppliers.
India and China are primary sources for atenolol and chlorthalidone, offering cost-effective manufacturing.
Regular audits, certifications, and transparent documentation are necessary for maintaining supply chain integrity.
Emerging trends favor sustainable, QbD-compliant manufacturing practices, influencing the API sourcing decision-making process.

FAQs

1. What are the main considerations when sourcing APIs for TENORETIC 50?
Quality compliance, regulatory approvals, supply reliability, cost, and supplier reputation are critical factors.

2. Which countries are primary producers of atenolol and chlorthalidone APIs?
India and China dominate API production for both atenolol and chlorthalidone, with Europe and North America sourcing selectively based on regulatory requirements.

3. How can companies mitigate risks associated with API supply disruptions?
By implementing diversified supplier relationships, engaging in long-term contracts, conducting regular audits, and maintaining buffer inventories.

4. Are there any upcoming regulatory changes impacting API sourcing?
Yes, initiatives like the US DSCSA and EU FMD increase traceability and authenticity requirements, compelling supply chain transparency.

5. What trends influence future API sourcing strategies?
Emphasis on sustainability, QbD practices, supply chain resilience, and compliance with evolving regulatory frameworks.

References:

[1] U.S. Food and Drug Administration (FDA). "API Supply Chain."
[2] World Health Organization (WHO). "Prequalification of Medicines Program."
[3] European Medicines Agency (EMA). "Manufacturing and Quality Control."
[4] Sourcing strategies for active pharmaceutical ingredients. Pharmaceutical Technology.
[5] Global API Market Outlook. IQVIA.

Bulk Pharmaceutical API Sources for TENORETIC 50